Dr Robert Weatheritt
Garvan Institute of Medical Research
$448,283
2021 - 2023
The Research
Triple-negative breast cancer (TNBC) is an aggressive form of cancer that accounts for around 10-20% of breast cancer cases. There are no treatments that specifically target this form of the disease and survival rates are lower than for other breast cancer types.
share
.svg)
